Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 2
2011 2
2012 2
2013 2
2014 4
2015 2
2016 1
2017 2
2018 3
2019 2
2020 4
2021 3
2022 6
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: MET receptor serves as a promising target in melanoma brain metastases.
Redmer T, Schumann E, Peters K, Weidemeier ME, Nowak S, Schroeder HWS, Vidal A, Radbruch H, Lehmann A, Kreuzer-Redmer S, Jürchott K, Radke J. Redmer T, et al. Among authors: lehmann a. Acta Neuropathol. 2024 Mar 27;147(1):63. doi: 10.1007/s00401-024-02719-9. Acta Neuropathol. 2024. PMID: 38536477 Free PMC article. No abstract available.
MET receptor serves as a promising target in melanoma brain metastases.
Redmer T, Schumann E, Peters K, Weidemeier ME, Nowak S, Schroeder HWS, Vidal A, Radbruch H, Lehmann A, Kreuzer-Redmer S, Jürchott K, Radke J. Redmer T, et al. Among authors: lehmann a. Acta Neuropathol. 2024 Feb 22;147(1):44. doi: 10.1007/s00401-024-02694-1. Acta Neuropathol. 2024. PMID: 38386085 Free PMC article.
A simple tool for evaluation of inflammation in psoriasis: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as markers in psoriasis patients and related murine models of psoriasis-like skin disease.
Kommoss KS, Bieler T, Ringen J, Lehmann A, Mihalceanu S, Hobohm L, Keller K, Brand A, Fischer B, Kramer D, Wild J, Waisman A, Enk A, Schäkel K, Heikenwälder M, Karbach S. Kommoss KS, et al. Among authors: lehmann a. J Mol Med (Berl). 2024 Feb;102(2):247-255. doi: 10.1007/s00109-023-02406-4. Epub 2023 Dec 21. J Mol Med (Berl). 2024. PMID: 38127137 Free PMC article.
DNA methylation-based classification of sinonasal tumors.
Jurmeister P, Glöß S, Roller R, Leitheiser M, Schmid S, Mochmann LH, Payá Capilla E, Fritz R, Dittmayer C, Friedrich C, Thieme A, Keyl P, Jarosch A, Schallenberg S, Bläker H, Hoffmann I, Vollbrecht C, Lehmann A, Hummel M, Heim D, Haji M, Harter P, Englert B, Frank S, Hench J, Paulus W, Hasselblatt M, Hartmann W, Dohmen H, Keber U, Jank P, Denkert C, Stadelmann C, Bremmer F, Richter A, Wefers A, Ribbat-Idel J, Perner S, Idel C, Chiariotti L, Della Monica R, Marinelli A, Schüller U, Bockmayr M, Liu J, Lund VJ, Forster M, Lechner M, Lorenzo-Guerra SL, Hermsen M, Johann PD, Agaimy A, Seegerer P, Koch A, Heppner F, Pfister SM, Jones DTW, Sill M, von Deimling A, Snuderl M, Müller KR, Forgó E, Howitt BE, Mertins P, Klauschen F, Capper D. Jurmeister P, et al. Among authors: lehmann a. Nat Commun. 2022 Nov 28;13(1):7148. doi: 10.1038/s41467-022-34815-3. Nat Commun. 2022. PMID: 36443295 Free PMC article.
Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue.
Vollbrecht C, Hoffmann I, Lehmann A, Merkelbach-Bruse S, Fassunke J, Wagener-Ryczek S, Ball M, Dimitrova L, Hartmann A, Stöhr R, Erber R, Weichert W, Pfarr N, Bohlmann L, Jung A, Dietmaier W, Dietel M, Horst D, Hummel M. Vollbrecht C, et al. Among authors: lehmann a. Virchows Arch. 2023 Apr;482(4):697-706. doi: 10.1007/s00428-022-03445-x. Epub 2022 Nov 11. Virchows Arch. 2023. PMID: 36367572 Free PMC article.
The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases.
Doll C, Steffen C, Beck-Broichsitter B, Richter M, Neumann K, Pohrt A, Lohneis P, Lehmann A, Heiland M, Stromberger C, Coordes A, Johrens K, Raguse JD. Doll C, et al. Among authors: lehmann a. Anticancer Res. 2022 May;42(5):2405-2413. doi: 10.21873/anticanres.15719. Anticancer Res. 2022. PMID: 35489745
Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies.
Kleo K, Jovanovic VM, Arndold A, Lehmann A, Lammert H, Berg E, Harloff H, Treese C, Hummel M, Daum S. Kleo K, et al. Among authors: lehmann a. J Cancer Res Clin Oncol. 2023 Mar;149(3):1049-1061. doi: 10.1007/s00432-022-03944-z. Epub 2022 Mar 5. J Cancer Res Clin Oncol. 2023. PMID: 35246724 Free PMC article.
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict).
Jank P, Lindner JL, Lehmann A, Pfitzner BM, Blohmer JU, Horst D, Kronenwett R, Denkert C, Schmitt WD. Jank P, et al. Among authors: lehmann a. Breast Cancer Res Treat. 2022 Jan;191(2):327-333. doi: 10.1007/s10549-021-06415-0. Epub 2021 Nov 16. Breast Cancer Res Treat. 2022. PMID: 34783927 Free PMC article.
37 results